Getinge AB (GETIb.ST)

GETIb.ST on Stockholm Stock Exchange

201.00SEK
11:29am EDT
Change (% chg)

12.70kr (+6.74%)
Prev Close
188.30kr
Open
189.30kr
Day's High
207.70kr
Day's Low
187.60kr
Volume
3,294,079
Avg. Vol
687,941
52-wk High
236.20kr
52-wk Low
147.00kr

GETIb.ST

Chart for GETIb.ST

About

Getinge AB is a Sweden-based company active in the healthcare sector. It is engaged in the provision of products and services for intensive care units, care units, sterilization centers, elderly care and companies and institutions active in the life sciences area. Its operations are divided into three business areas. The Medical... (more)

Overall

Beta: 0.71
Market Cap(Mil.): kr41,874.78
Shares Outstanding(Mil.): 222.38
Dividend: 2.80
Yield (%): 1.49

Financials

  GETIb.ST Industry Sector
P/E (TTM): 27.65 37.14 35.63
EPS (TTM): 6.81 -- --
ROI: 3.88 11.81 14.92
ROE: 9.43 13.86 15.77
Search Stocks

BRIEF-Getinge CEO: "Our home has to be healthy in order to add parts to the company"

Sept 2 - Getinge CEO Alex Myers presenting at company's Capital Markets Day:

7:08am EDT

Getinge eyes profit boost with new restructuring plan

STOCKHOLM, Sept 2 - Swedish medical technology group Getinge mapped out a new restructuring plan on Wednesday aimed at boosting growth and efficiency, and set fresh financial targets, sending shares higher.

6:58am EDT

BRIEF-Getinge sees no FDA-related restructuring costs post-2015

* Sees no additional restructuring costs relating to FDA consent decree charged after 2015-presentation material

6:52am EDT

BRIEF-Getinge announces efficiency plan, sets new financial targets

* Getinge to strengthen competitiveness with a comprehensive transformation program focused on growth, efficiency and a new organization

6:24am EDT

BRIEF-Getinge CEO: Future guidance to focus more on growth than margins

* Getinge ceo says financial guidance ahead likely to focus more on sales, profit growth, not on margins

15 Jul 2015

BRIEF-Getinge CEO: constant price pressure of a couple of pct

* CEO says sees constant price pressure of a couple of percent Further company coverage:

15 Jul 2015

UPDATE 1-New Getinge CEO vows improvement plan as Q1 profit lags

* Q1 EBITA 717 mln SEK vs forecast 835 mln (Adds detail, background)

20 Apr 2015

Getinge Q1 core profit lags forecasts

STOCKHOLM, April 20 - Swedish medical technology group Getinge posted a first-quarter core profit below analyst forecasts on Monday and stood by its outlook for better growth in 2015.

20 Apr 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Wright Reports
$75.00
Provider : Sadif Analytics Prime
$10.00
Provider : Reuters Investment Profile
$20.00
Provider : GlobalData
$125.00
Provider : Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks